Roche sänker budet på Genentech

I juli ifjol var budet 89 dollar per aktie. Då sa Genentechs styrelse nej tack. Nu meddelar läkemedelsjätten att man sänker budet och vänder sig direkt till småägarna.

Grönt ljus för Getinges bolagsköp

Medicinteknikföretaget Getinge har fått godkännande från den amerikanska konkurrensmyndigheten Federal Trade Commission, FTC för köpet av bolaget Datascope Corp. Efter klartecken från amerikanska myndigheter kan den segdragna affären nu slutföras.

Go ahead for leg wound study

Tripep starts a phase II-study of their wound healing joint venture project.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

Biotage is regrouping

The Swedish company Biotage takes yet another step in streamlining efforts, by outsourcing all instrument production to contract manufacturers.

Vitamin D is mental health aid

Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Swedish nanotech crosses the Atlantic

Genovis signs distribution agreement Finnzymes in US.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

Eli Lilly writes biotech fine history

The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.

Medtech companies find new beam technique

The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.

Pharma is a safe market

Pharma is the best industry to invest in. That states leaders from risk capital companies, interviewed by the Economist Intelligence Unit.

New map of eye proteins

A new mapping of proteins in the eye opens the door for new treatments of eye diseases in the future.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

Parnevik firm in Swiss osteoporosis deal

The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.

Danish biorefinery can save US billions

The Danish Inbicon biorefinery process could save the US billions on foreign oil, the organization states.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Sales Representative, Applied Biosystems

Grape extract kills cancer cells

Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 members and a very busy event calender.